JP Morgan Chase
DMAA

JP Morgan Chase’s Drugs Made In America Acquisition Corp DMAA Stock Holding History

JP Morgan Chase’s Portfolio DMAA Stock Details DMAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$531K Buy
49,891
+10
+0% +$106 ﹤0.01% 5054
2026
Q1 		$523K Buy
49,881
+60
+0.1% +$627 ﹤0.01% 4969
2025
Q4 		$517K Sell
49,821
-49,869
-50% -$515K ﹤0.01% 5011
2025
Q3 		$1.02M Buy
+99,690
New +$1.02M ﹤0.01% 4571

Other funds holding DMAA

KIM
Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return
MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.69% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.69% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.5% 1-Year Est. Return
SAMU
SONA Asset Management (US) New York $4.76B AUM 23.76% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

JP Morgan Chase's DMAA Position: Q2 2026 in Review

JP Morgan Chase increased its Drugs Made In America Acquisition Corp (DMAA) stake by 0.02% in Q2 2026, buying an estimated $106 and bringing the position to 49,891 shares worth $531K. The position accounts for ﹤0.01% of the portfolio, ranked #5054.

JP Morgan Chase first reported a position in DMAA in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.02M in Q3 2025. 18 funds tracked by Wall St. Rank hold DMAA as of Q2 2026.

  • JP Morgan Chase held 49,891 shares of Drugs Made In America Acquisition Corp worth $531K as of Q2 2026.
  • JP Morgan Chase bought 10 Drugs Made In America Acquisition Corp shares in Q2 2026, an estimated $106.
  • Drugs Made In America Acquisition Corp made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #5054 holding.
  • JP Morgan Chase first reported a position in Drugs Made In America Acquisition Corp in Q3 2025 and has held it in 4 quarters since.
  • JP Morgan Chase's Drugs Made In America Acquisition Corp position peaked at $1.02M in Q3 2025.
  • 18 funds tracked by Wall St. Rank held Drugs Made In America Acquisition Corp as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.